Fact CheckerSign in

NCT06594107Recruiting

Factors for the Onset and Course of Axial Spondylitis

Faktorer För Uppkomst Och Förlopp Av Axial Spondylartrit

Source: ClinicalTrials.gov · Last updated 24 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In a research project, investigators want to study the course of the disease of axial spondylitis: the causes of disease onset, prognosis, and treatment effects. The goal is to improve treatment and in the long run also prevention of the disease. The project has a focus on the body\'s own substance prostaglandin, and its proinflammatory role in spondylitis, but also other substances may be analyzed in blood and urine samples. The purpose of the research project is include newly diagnosed treatment-naive patients with axial spondyloarthritis, to follow them after 1 and 2 years after treatment start, to collect clinical data, questionnaires, blood and urinsamples to find blood or urine markers that can be used for precision therapy of axial spondylitis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1000 (estimated)
First submitted
10 Sept 2024
Start date
1 Sept 2022
Primary completion date
31 Dec 2035
Lead sponsor
Karolinska Institutet
NCT number
NCT06594107

What you commit to

  • Study type: Observational
  • Planned participants: 1000
  • From 1 Sept 2022 to the primary completion date, 31 Dec 2035
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • ongoing infection
  • ongoing malignancy

Other

  • DMARD treatment,

Who the study is looking for

  • newly diagnosed patients with axial spondyloarthritis
  • treatment-naive
  • 18 years of age or older
  • Swedish-speaking
  • Able to give informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karolinska University Hospital
Coordinator of this site? Confirm its status
HuddingeSwedenRecruiting
Center for Rheumatology Stockholm
Coordinator of this site? Confirm its status
StockholmSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.